Please sign in to follow a disease.
Pediatric osteosarcoma
MONDO:0002623An osteosarcoma occurring in childhood.
Also known as: osteosarcoma, childhood osteogenic sarcoma, childhood osteosarcoma, childhood osteosarcoma (disease), osteosarcoma (disease) of childhood, paediatric osteosarcoma (disease), pediatric osteosarcoma, pediatric osteosarcoma (disease)
2938 clinical trials for this condition and its sub-types, 8 tagged with Pediatric osteosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Pediatric osteosarcoma
-
Childhood extraosseous osteosarcoma 0 trials
-
Childhood intracortical osteosarcoma 0 trials
-
Childhood parosteal osteosarcoma 0 trials
-
Engineered immune cells aim to stop bone Cancer's return in kids
Disease control Recruiting nowThis phase II trial tests whether a single infusion of B7-H3 CAR T cells, given after standard chemotherapy, can prevent the return of high-risk osteosarcoma in children. The study will enroll 41 participants who have completed upfront chemotherapy. Researchers will monitor how l…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Experimental combo aims to tackle tough bone cancer
Disease control Recruiting nowThis early-stage trial tests a new drug called tegavivint combined with the chemotherapy gemcitabine in 24 people whose osteosarcoma (a type of bone cancer) has returned or not responded to prior treatment. The main goal is to find the safest dose of tegavivint when given with ge…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy targets childhood sarcomas that returned
Disease control Recruiting nowThis early-stage study tests a new treatment for children and young adults up to age 21 with sarcomas that have come back or not responded to standard therapy. The treatment combines a special type of immune cell (B7-H3-CAR T cells) with targeted radiation and chemotherapy to see…
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC